comparemela.com

Latest Breaking News On - Australia clinical - Page 1 : comparemela.com

대웅제약, 탈모치료 주사제 개발 본격 돌입…'호주 임상 1상 승인' : 네이버 뉴스

대웅제약, 탈모치료 주사제 개발 본격 돌입…'호주 임상 1상 승인' : 네이버 뉴스
naver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naver.com Daily Mail and Mail on Sunday newspapers.

Australia
Japan
United-states
Australia-clinical
Daewoong-pharmaceutical
Daewoong-pharmaceutical-australia
Daewoong-pharmaceutical-clinical

인벤티지랩, '탈모치료 장기지속형 주사제' 호주 임상 승인

인벤티지랩, '탈모치료 장기지속형 주사제' 호주 임상 승인
metroseoul.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metroseoul.co.kr Daily Mail and Mail on Sunday newspapers.

Australia
United-states
Development-the-agreement
Testament-development-australia
Australia-clinical
New-testament-development-australia
Clinical-planning

인벤티지랩, '탈모치료 장기지속형 주사제' 호주 임상 승인

인벤티지랩, '탈모치료 장기지속형 주사제' 호주 임상 승인
metroseoul.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metroseoul.co.kr Daily Mail and Mail on Sunday newspapers.

Australia
United-states
Development-the-agreement
Testament-development-australia
Australia-clinical
New-testament-development-australia
Clinical-planning
ஆஸ்திரேலியா
ஒன்றுபட்டது-மாநிலங்களில்
மருத்துவ-திட்டமிடல்

대웅제약, 폐섬유증 물질 임상 1상서 상업화 가능성 재확인

대웅제약, 폐섬유증 물질 임상 1상서 상업화 가능성 재확인
news1.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news1.kr Daily Mail and Mail on Sunday newspapers.

Australia
Daewoong-pharmaceutical-development
Mass-clinical
Daewoong-pharmaceutical
Australia-clinical
New-testament

올리패스, OLP-1002 호주 임상 2a 시험 허가 신청

올리패스, OLP-1002 호주 임상 2a 시험 허가 신청
mtn.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mtn.co.kr Daily Mail and Mail on Sunday newspapers.

Australia
Australia-clinical
New-testament
Money-today
Bar-money-today

vimarsana © 2020. All Rights Reserved.